Waist hip ratio: an anatomical predictive marker of risk of PCOS


  • Sumitra Yadav Department of Obstetrics and Gynecology, MGMMC, Indore, Madhya Pradesh, India
  • Ritu Tarware Department of Obstetrics and Gynecology, MGMMC, Indore, Madhya Pradesh, India




BMI, Metabolic disorder, PCOS


Background: Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders seen in infertility clinic of Gynae OPD. It is basically is disease of metabolic disorder and requires ultrasound and hormonal assay for its diagnosis.

Methods: The study was carried out in the GOPD of MGM medical College and M.Y. Hospital Indore (M.P.) India. It included 200 women in the age group 18-40 years diagnosed as PCOS and who were compared with 200 women of same age group without PCOS. The height, weight BMI and waist hip ratio were measured and analyzed statistically.

Results: The present study shows that women with PCOS had higher incidence of acne hirsutism and irregular menses (p<0.0001), women with PCOS had higher mean ovarian volume measurement (11±1.4cc) compared to female controls who had lower volume of ovary with a range of (7.94±2.34cc. (p<0.0001) as calculated by USG by sonologist.

Conclusions: The presence of central obesity, (waist hip ratio >0.87) is an indication for presence of PCOS. Thus, these patients may undergo further hormone evaluation and this simple measurement can help to screen out PCOS from general population. This prevents financial burden on low resource settings.


Frank S. Polysystic ovary syndrome. N Engl J Med. 1995;333(13):853-61.

Kellmann M, Martins, WP, Raine Fenning N, Terms and thresholds for the ultrasound evaluation of the ovaries in women with hyperandrogenic anovulation. Hum Reprod. 2014;20(3):463-64

Diamanti – Kandaraskin E , KAndaraskin H, Hegeo RS : The role of genes and environment in the etiology of PCOS. Endo 2006;30(1):19-26

Dumesic DA, Abbott DH, Eisner JR, Goy RW. Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil Steril. 1997 ;67(1):155-63.

Abbott DH, Dumesic DA, Franks, Developments origin of polycystic ovary syndrome- a hypothesis. J Endocrinol. 2002;174(1):1-5

Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome, Lancet. 2005; 365(9468):1415-28.

Kennedy A. Polycystic ovarian syndrome. In Ahuja AT (ed) Diagnostic imaging Ultra Sound. 1st ed. Canada , Amirsy / Elsevir, 2007 p. 94-95

Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008;89(3):649-55.

Goverde AJ, Van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reproduct. 2008;24(3):710-7.

Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clinic Nutri. 2004;79(3):379-84.

Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma TK, George K. Prevalance of metabolic syndrome in women with polycystic ovary syndromeattending an infertility clinic in atertiary care hospital in South India. J Hum Reprod Sci. 2012;5(1):26-31.






Original Research Articles